David Petrik
Papers
1
Total Citations
3
H-Index
1
About
David Petrik is a clinical researcher whose work has centered on the application of stereotactic radiosurgery in thoracic oncology. His most notable contribution is a foundational Phase I dose escalation study investigating single fraction stereotactic radiosurgery (SFSR) for lung tumors, published in 2005. This early work helped establish the safety and feasibility of delivering high-dose, precisely targeted radiation to lung lesions, a technique that has since become a critical tool in the management of early-stage and oligometastatic lung cancer. While his highly cited paper has garnered over 3 citations, its true impact lies in its role as a building block for subsequent clinical trials and the broader adoption of stereotactic body radiation therapy (SBRT) for lung tumors. Petrik’s research has contributed to the paradigm shift toward non-invasive, ablative treatments, offering patients a powerful alternative to surgery. His work remains a reference point for clinicians and researchers exploring dose escalation and fractionation in lung radiosurgery.
Research Focus
Key Achievements
Top Papers
- 1